Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance

US12102454B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12102454-B2
Application numberUS-202217742088-A
CountryUS
Kind codeB2
Filing dateMay 11, 2022
Priority dateDec 31, 2012
Publication dateOct 1, 2024
Grant dateOct 1, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.

First claim

Opening claim text (preview).

What is claimed is: 1. A system for managing diabetes during pregnancy, the system comprising: a continuous glucose monitor comprising a sensor configured to be positioned in interstitial tissue of a patient, such that the continuous glucose monitor is configured to monitor glucose levels of the patient; and a display device in wireless communication with the continuous glucose monitor to receive the monitored glucose levels, wherein the display device comprises: an input device, a display, a non-volatile, non-transitory memory storing a glucose data processing program, and a processor coupled with the non-volatile, non-transitory memory, and configured to execute the glucose data processing program to cause the processor to: adjust a threshold for determining a glycemic risk level from a first setting to a second setting that is different than the first setting based on a pregnant condition of the patient, wherein the threshold comprises a fraction of a period of time in which glucose levels are below a predetermined low glucose level, wherein the first setting comprises a first fraction of the period of time in which glucose levels are below the predetermined low glucose level and the second setting comprises a second fraction of the period of time in which glucose levels are below the predetermined low glucose level, and wherein the second fraction is greater than the first fraction, determine a glucose metric for one or more periods of time based on the received monitored glucose levels, determine the glycemic risk level for the one or more periods of time based on a comparison of the determined glucose metric to the threshold, and determine a treatment recommendation based at least in part on the glycemic risk level, wherein the treatment recommendation comprises a modification to self-care behavior. 2. The system of claim 1 , wherein the second setting is more tolerant of hypoglycemia than the first setting. 3. The system of claim 1 , wherein the glycemic risk level comprises a hypoglycemia risk level. 4. The system of claim 1 , wherein the processor is further configured to receive a selection from the input device of the display device to adjust the threshold. 5. The system of claim 1 , wherein the threshold is selected from a predetermined list of settings. 6. The system of claim 5 , wherein the predetermined list of settings comprises small, medium, or large. 7. The system of claim 1 , wherein the processor is further caused to display a graph of the glucose levels and a visual indication of the glycemic risk level for the one or more periods of time on the display. 8. A method for managing diabetes during pregnancy, the method comprising: monitoring glucose levels by a continuous glucose monitor comprising a sensor configured to be positioned in interstitial tissue of a patient; wirelessly communicating the monitored glucose levels from the continuous glucose monitor to a display device; adjusting a threshold for determining a glycemic risk level from a first setting to a second setting that is different than the first setting based on a pregnant condition of the patient, wherein the threshold comprises a fraction of a period of time in which glucose levels are below a predetermined low glucose level, wherein the first setting comprises a first fraction of the period of time in which glucose levels are below the predetermined low glucose level and the second setting comprises a second fraction of the period of time in which glucose levels are below the predetermined low glucose level, and wherein the second fraction is greater than the first fraction; determining, by a processor of the display device, a glucose metric for one or more periods of time based on the glucose levels; determining, by the processor of the display device, the glycemic risk level for the one or more periods of time based on a comparison of the glucose metric to the threshold; and determining a treatment recommendation based at least in part on the comparison of the glucose metric to the glucose metric threshold, wherein the treatment recommendation comprises a modification to self-care behavior. 9. The method of claim 8 , wherein the second setting is more tolerant of hypoglycemia than the first setting. 10. The method of claim 8 , wherein the glycemic risk level comprises a hypoglycemia risk level. 11. The method of claim 8 , wherein the glycemic risk level comprises one of high, moderate or low risk. 12. The method of claim 8 , further comprising displaying a graph of the glucose levels and a visual indication of the glycemic risk level for the one or more periods of time on a display of the display device. 13. A system for managing diabetes during pregnancy, the system comprising: a continuous glucose monitor comprising a sensor configured to be positioned in interstitial tissue of a patient, such that the continuous glucose monitor is configured to monitor glucose levels of the patient; and a display device in wireless communication with the continuous glucose monitor to receive the monitored glucose levels, wherein the display device comprises: an input device, a display, a non-volatile, non-transitory memory storing a glucose data processing program, and a processor coupled with the non-volatile, non-transitory memory, and configured to execute the glucose data processing program to cause the processor to: adjust a threshold for determining a glycemic risk level from a first setting to a second setting that is different than the first setting based on a pregnant condition of the patient, wherein the threshold comprises a fraction of a period of time in which glucose levels are below a predetermined low glucose level, wherein the first setting comprises a first fraction of the period of time in which glucose levels are below the predetermined low glucose level and the second setting comprises a second fraction of the period of time in which glucose levels are below the predetermined low glucose level, and wherein the second fraction is greater than the first fraction, determine a glucose metric for one or more periods of time based on the received monitored glucose levels, determine the glycemic risk level for the one or more periods of time based on a comparison of the determined glucose metric to the threshold, and determine a treatment recommendation based at least in part on the glycemic risk level, wherein the treatment recommendation comprises an adjustment to a medication dose. 14. A method for managing diabetes during pregnancy, the method comprising: monitoring glucose levels by a continuous glucose monitor comprising a sensor configured to be positioned in interstitial tissue of a patient; wirelessly communicating the monitored glucose levels from the continuous glucose monitor to a display device; adjusting a threshold for determining a glycemic risk level from a first setting to a second setting that is different than the first setting based on a pregnant condition of the patient, wherein the threshold comprises a fraction of a period of time in which glucose levels are below a predetermined low glucose level, wherein the first setting comprises a first fraction of the period of time in which glucose levels are below the predetermined low glucose level and the second setting comprises a second fraction of the period of time in which glucose levels are below the predetermined low glucose level, and wherein the second fraction is greater than the first fraction; determining, by a processor of the display device, a glucose metric for one or more periods of time based on the glucose levels; determining, by t

Assignees

Inventors

Classifications

  • for computer-aided diagnosis, e.g. based on medical expert systems · CPC title

  • for calculating health indices; for individual health risk assessment · CPC title

  • Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots · CPC title

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

  • A61B5/7275Primary

    Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12102454B2 cover?
A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose…
Who is the assignee on this patent?
Abbott Diabetes Care Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/7275. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).